Search Results - "Drobacheff, C"

Evaluation of a novel 308-nm monochromatic excimer light delivery system in dermatology: a pilot study in different chronic localized dermatoses by Aubin, F., Vigan, M., Puzenat, E., Blanc, D., Drobacheff, C., Deprez, P., Humbert, P., Laurent, R.

“…Summary Background  Recently, units have been developed that are capable of delivering large fluences of narrowband ultraviolet (UV) B selectively to cutaneous…”
Get full text

Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype by MILLON, L, MANTEAUX, A, REBOUX, G, DROBACHEFF, C, MONOD, M, BARALE, T, MICHEL-BRIAND, Y

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort by Cuzin, Lise, Pugliese, Pascal, Katlama, Christine, Bani-Sadr, Firouzé, Ferry, Tristan, Rey, David, Lourenco, Jeremy, Bregigeon, Sylvie, Allavena, Clotilde, Reynes, Jacques, Cabié, André

“…Abstract Objectives To analyse the frequency and causes of treatment discontinuation in patients who were treated with an integrase strand transfer inhibitor…”
Get full text

DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) Syndrome Associated with Nevirapine Therapy by Yazid Bourezane, Dominique Salard, Bruno Hoen, Sylvie Vandel, Christine Drobacheff, Laurent, René

“…Hypersensitivity syndrome (HSS) is a serious, drug-induced systemic condition that has been reported mostly in association with aromatic anticonvulsants,…”
Get full text

Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study by Ursenbach, Axel, Max, Vincent, Maurel, Marine, Bani-Sadr, Firouzé, Gagneux-Brunon, Amandine, Garraffo, Rodolphe, Ravaux, Isabelle, Robineau, Olivier, Makinson, Alain, Rey, David

“…Integrase strand transfer inhibitors (INSTIs) are increasingly used in patients living with HIV due to their safety, effectiveness and high genetic barrier…”
Get full text

No increased risk of Kaposi sarcoma relapse in patients with controlled HIV‐1 infection after switching protease inhibitor‐based antiretroviral therapy by Makinson, Alain, Arvieux, Cedric, Chirouze, C., Brunel, AS, Chevalier, E., Mrozek, N., Aumeran, C., Goncalvez, E., Lamaury, I., Ouissa, R., Receveur, MC, Clavel, C., Markowicz, S., Merrien, D., Guimard, T., Bollangier, O., Boucher, D., Boibieux, A., Cannesson, O., Chiarello, P., Ferry, T., Pouderoux, C., Triffault‐Fillit, C., Valour, F., Charre, C., Trabaud, M.A., Belkhir, AY, Madrid, A., Tissot‐Dupont, H., Brégigeon, S., Ducassou, M.J., Galie, S., Colson, H., Ivanova, A., Debreux, C., Cabras, O., Dupin de Majoubert, R., Najioullah, F., Pasquier, J., Varache, C., Atoui, N., Montes, B., Lefèvre, B., Jeanmaire, E., Hénard, S., Frentiu, E., Bouillon, MP, Raffi, F., Billaud, E., Biron, C., Bonnet, B., Bouchez, S., Deschanvres, C., Grossi, O., Morineau, P., Soria, A., Pugliese, P., Chirio, D., Cua, E., Dellamonica, P., De Monte, A., Durant, J., Maka, A., Giaché, S., Lerolle, N., Deradji, O., Castro, A., Ghosn, J., Lescure, FX, Le Gac, S., Duvivier, C., Alby‐Laurent, F., Amazzough, K., Bossi, P., Jidar, K., Lafont, E., Lourenco, J., Valantin, MA, Blanc, C., Katlama, C., Romaru, J., Tattevin, P., Souala, F., Benezit, F., Pronier, C., Morlat, C., Poisson‐Vannier, M., Jovelin, T., Frésard, A., Ronat, V., Lucht, F., Batard, ML, Delobel, P., Biezunski, N., Martin‐Blondel, G., Piffaut, M., Saune, K., Ajana, F., Baclet, V., Pradier, M.

“…Objectives Our aim was to assess if switching from a protease inhibitors (PI)‐based regimen to a PI‐free one is associated with an increased risk of Kaposi…”
Get full text

Kaposi sarcoma among people living with HIV in the French DAT’AIDS cohort between 2010 and 2015 by Poizot‐Martin, I., Obry‐Roguet, V., Lions, C., Huleux, T., Ferry, T., Allavena, C., Bani‐Sadr, F., Lamaury, I., Brégigeon, S., Muret, P., Lesens, O., Prouteau, J., Bonijoly, T., Daniel, C., Perré, P., Guimard, T., Becker, A., Boibieux, A., Cotte, L., Degroodt, S., Colson, P., Meddeb, L., Mokhtari, M., Motte, A., Raoux, A., Ravaux, I., Tamalet, C., Tissot Dupont, H., Orticoni, M., Galinier, A., Martinet, P., Abel, S., Cabras, O., Cuzin, L., Guitteaud, K., Pierre‐François, S., Osei, L., Atoui, N., Boyer, L., Hoen, B., Bernaud, C., Biron, C., Hall, N., Ferré, V., André‐Garnier, E., Rodallec, A., Lefebvre, M., Aubry, O., Breaud, S., Chirio, D., Garraffo, R., Mondain, V., Naqvi, A., Perbost, I., Pradier, C., Prouvost‐Keller, B., Roger, P.M., Wehrlen‐Pugliese, S., Hocqueloux, L., Sève, A., Boulard, C., Goujard, C., Quertainmont, Y., Teicher, E., Deradji, O., Rioux, C., Lariven, S., Lescure, F.X., Le Gac, S., Charpentier, C., Peytavin, G., Bossi, P., Cessot, G., Consigny, P.H., Danion, F., Goesch, J., Lanternier, F., Pilmis, B., Touam, F., Berger, J.L., Brodard, V., Revest, M., Lemaitre, F., Poisson‐Vanier, M., Jovelin, T., Fischer, P., Cheneau, C., Mautort, E., Fafi‐Kremer, S., Alvarez, M., Biezunski, N., Debard, A., Lansalot, P., Saune, K., Aïssi, E., Baclet, V., Pradier, M., Robineau, O., Viget, N., Valette, M.

“…Background Although antiretroviral therapy (ART) has reduced the risk of Kaposi sarcoma (KS), KS cases still occur in HIV‐infected people. Objective To…”
Get full text

Anal human papillomavirus DNA screening by hybrid Capture II in human immunodeficiency virus-positive patients with or without anal intercourse by DROBACHEFF, C, DUPONT, P, MOUGIN, C, BOUREZANE, Y, CHALLIER, B, FANTOLI, M, BETTINGER, D, LAURENT, R

“…High risk human papillomaviruses (HPVs) have emerged as risk factors for anal carcinoma, of which incidence is higher in HIV-positive patients than in the…”
Get full text

Nonspecific Secretory Immunity in HIV-Infected Patients With Oral Candidiasis by Bard, E, Laibe, S, Clair, S, Biichlé, S, Millon, L, Drobacheff, C, Bettinger, D, Seillès, E, Meillet, D

“…Buccal and digestive tract opportunistic infections occur frequently in patients infected by HIV. In this study, we measured lysozyme (Lz), lactoferrin (Lf),…”
Get full text

Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis by Drobacheff, C, Millon, L, Monod, M, Piarroux, R, Robinet, E, Laurent, R, Meillet, D

“…The aim of this study was to explore anti-Candida albicans systemic and mucosal humoral responses against Candida virulence antigens such as somatic antigen…”
Get more information

Evaluation of internal transcribed spacer region of ribosomal DNA sequence analysis for molecular characterization of Candida albicans and Candida dubliniensis isolates from HIV-infected patients by MILLON, L, PIARROUX, R, DROBACHEFF, C, MONOD, M, GRENOUILLET, F, BULLE, B, BOLE, J, BLANCARD, A, MEILLET, D

“…Molecular typing systems have been needed to study Candida colonization in HIV-infected patients, particularly for investigating virulence and fluconazole…”
Get full text

Comparative risk of failure of ABC/3TC or TDF/FTC based first‐line regimens in patients with a high viral load by Flandre, P, Pugliese, P, Allavena, C, Katlama, C, Cotte, L, Cheret, A, Cabié, A, Rey, D, Chirouze, C, Cuzin, L, Obry‐Roguet, V., Bregigeon, S., Poizot‐Martin, I., Marchou, B., Massip, P., Bonnet, E., Obadia, M., Alvarez, M., Porte, L., Delobel, P., Chauveau, M., Garipuy, D., Bernard, J., Lepain, I., Marcel, M., Puntis, E., Sauné, K., Ceppi, C., Cua, E., Cottalorda, J., Dellamonica, P., Demonchy, E., Durant, J., Etienne, C., Ferrando, S., Garraffo, R., Mondain, V., Oran, N., Perbost, I., Pillet, S., Prouvost‐Keller, B., Pradier, C., Wehrlen‐Pugliese, S., Sausse, S., Roger, P.M., Bernaud, C., Billaud, E., Biron, C., Bonnet, B., Bouchez, S., Boutoille, D., Hall, N., Jovelin, T., Morineau, P., Reliquet, V., Hue, H., Larmet, L., Pineau, So, Ferré, V., André‐Garnier, E., Rodallec, A., Choisy, P., Yazdanpanah, Y., Landman, R., Duvivier, C., Agher, R., Consigny, P.H., Cessot, G., Touam, F., Usubillaga, R., Benhadj, K., Abel, S., Pierre‐François, S., Ouka, M., Martial, J., Ebel, E., Cheneau, C, Priester, M, Batard, ML, Bernard‐Henry, C, Mautort, E, Drobacheff‐Thiébaut, C., Faller, J.P., Faucher, J.F., Foltzer, A., Jacomet, C., Laurichesse, H., Lesens, O., Aumeran, C., Baud, O., Beytout, J., Coban, D., Casanova, S., Rouger, C., Peyramond, D., Chidiac, C., Ader, F., Boibieux, A., Miailhes, P, Perpoint, T.

“…Objectives To compare the efficacy, in current clinical practice, of first regimens containing abacavir with lamivudine (ABC/3TC) or tenofovir with…”
Get full text

Ingrown toenail and indinavir: case-control study demonstrates strong relationship by BOUREZANE, Y, THALAMY, B, VIEL, J.-F, BARDONNET, K, DROBACHEFF, C, GIL, H, VUITTON, D.-A, HOEN, B

“…Indinavir was recently reported to induce paronychia and ingrown toenails (ITN) in 42 HIV-infected patients. Similar manifestations were described in 12…”
Get full text

Treatment of scleroderma with oral 1,25-dihydroxyvitamin D3: evaluation of skin involvement using non-invasive techniques. Results of an open prospective trial by Humbert, P, Dupond, J L, Agache, P, Laurent, R, Rochefort, A, Drobacheff, C, de Wazieres, B, Aubin, F

“…1,25-dihydroxycholecalciferol (1,25 (OH)2 D3) causes dose-dependent inhibition of fibroblast growth and collagen synthesis and has numerous immunoregulatory…”
Get more information

Cutaneous reaction to ultraviolet irradiation in human-immunodeficiency-virus-infected patients. A case-control study by Aubin, F, Parriaux, N, Robert, C, Blanc, D, Drobacheff, C, Laurent, R, Humbert, P

“…HIV-infected patients, like renal transplant recipients, are at increased risk of developing skin cancer in photoexposed areas. Previous studies demonstrated…”
Get more information

External genital warts (condyloma) by Bouscarat, F, Dupin, N, Janier, M, Drobacheff, C, Milpied, B, Vexiau-Robert, D

Get full text

Augmentation des synthèses locales de la lactoferrine et du lysozyme chez des patients infectés par le virus de l'immunodéficience humaine avec candidose oropharyngée : rôle de l'immunité muqueuse innée ? by Laibe, S., Biichlé, S., Clair, S., Bard, E., Millon, L., Drobacheff, C., Meillet, D.

“…Malgré l'utilisation de la trithérapie, la candidose oropharyngée (COP) demeure une des infections les plus fréquentes chez les patients infectés par le virus…”
Get full text

Lichen planus of the oesophagus by Jobard-Drobacheff, C, Blanc, D, Quencez, E, Zultak, M, Paris, B, Ottignon, Y, Agache, P

Get more information

Facteurs prédictifs de la réponse virologique à un premier traitement antirétroviral by Faucher, J.-F., Challier, B., Chirouze, C., Drobacheff, C., Fischer, P., Lang, J.-M., Boyer, L., May, T., Froidure, M., Chavanet, P., Lescure, F.-X., Strady, C., Hoen, B.

“…Au cours de l’année 1999, les associations d’antirétroviraux de première ligne pour traiter l’infection par le VIH se sont diversifiées. L’objectif de notre…”
Get full text

Pregnancy may be followed by an inflexion of the immune reconstitution in HIV‐infected women who receive antiretroviral drugs before conception by Le Moing, V, Taïeb, A, Longuet, P, Lewden, C, Delcey, V, Drobacheff, MC Thiebaut, Chêne, G, Leport, C

“…Background Whether pregnancy has an impact on the evolution of CD4 cell counts in women treated with highly potent antiretrovirals before conception remains…”
Get full text